These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30543397)

  • 1. RNA Micelles for the Systemic Delivery of Anti-miRNA for Cancer Targeting and Inhibition without Ligand.
    Yin H; Wang H; Li Z; Shu D; Guo P
    ACS Nano; 2019 Jan; 13(1):706-717. PubMed ID: 30543397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
    Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
    ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.
    Lee TJ; Yoo JY; Shu D; Li H; Zhang J; Yu JG; Jaime-Ramirez AC; Acunzo M; Romano G; Cui R; Sun HL; Luo Z; Old M; Kaur B; Guo P; Croce CM
    Mol Ther; 2017 Jul; 25(7):1544-1555. PubMed ID: 28109960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.
    Binzel DW; Shu Y; Li H; Sun M; Zhang Q; Shu D; Guo B; Guo P
    Mol Ther; 2016 Aug; 24(7):1267-77. PubMed ID: 27125502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice.
    Haque F; Xu C; Jasinski DL; Li H; Guo P
    Methods Mol Biol; 2017; 1632():359-380. PubMed ID: 28730451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model.
    Tan X; Kim G; Lee D; Oh J; Kim M; Piao C; Lee J; Lee MS; Jeong JH; Lee M
    Biomater Sci; 2018 Jan; 6(2):407-417. PubMed ID: 29340361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of small noncoding RNA for glioblastoma.
    Yoo JY; Yeh M; Kaur B; Lee TJ
    Cancer Lett; 2021 Mar; 500():274-280. PubMed ID: 33176185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
    Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
    Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
    Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
    Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
    Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
    J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-based therapeutics and tumor targeted delivery in cancer.
    Kara G; Calin GA; Ozpolat B
    Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Delivery Vehicles of siRNA for Enhanced Cancer Targeting.
    Kim HJ; Yi Y; Kim A; Miyata K
    Biomacromolecules; 2018 Jul; 19(7):2377-2390. PubMed ID: 29864287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy.
    Ma Z; Hu P; Guo C; Wang D; Zhang X; Chen M; Wang Q; Sun M; Zeng P; Lu F; Sun L; She L; Zhang H; Yao J; Yang F
    Int J Nanomedicine; 2019; 14():5527-5540. PubMed ID: 31413561
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
    Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
    RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential delivery of VEGF siRNA and paclitaxel for PVN destruction, anti-angiogenesis, and tumor cell apoptosis procedurally via a multi-functional polymer micelle.
    Yang Y; Meng Y; Ye J; Xia X; Wang H; Li L; Dong W; Jin D; Liu Y
    J Control Release; 2018 Oct; 287():103-120. PubMed ID: 30144476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pH-Triggered Triblock Nanocarrier Enabled Highly Efficient siRNA Delivery for Cancer Therapy.
    Du L; Zhou J; Meng L; Wang X; Wang C; Huang Y; Zheng S; Deng L; Cao H; Liang Z; Dong A; Cheng Q
    Theranostics; 2017; 7(14):3432-3445. PubMed ID: 28912886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
    Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
    ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
    Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
    Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.